BIO-Europe 2026
Talk Presenting Companies (Theatre B) track
Autoimmune/Inflammation: Genrix Biopharmaceutical Co., Ltd.
Tue, Nov 10, 2026 · 9:00–9:15 AM CET Koelnmesse
About this session
Genrix Biopharmaceutical is a premier, fully integrated biopharmaceutical company headquartered in southwest China. Established in 2015 and listed on the SSE Star Market, Genrix has rapidly evolved from a cutting-edge research platform into a commercial-scale industry leader.
Speaker
-
Head of Business Development · Genrix Biopharmaceutical
Speaker